艾叶甲醇提取物通过抑制PI3K-AKT通路激活抗甲型流感病毒
本研究评估艾叶甲醇提取物(AAE)的抗甲型流感病毒(IAV)作用及机制。体外实验显示AAE具广谱抗流感活性且细胞毒性低;多组学分析提示其靶向宿主PI3K-AKT通路,实验验证AAE通过抑制该通路激活诱导感染细胞凋亡并减轻过度炎症反应。在致死性H1N1小鼠模型中,AAE治疗显著提高生存率、降低肺病毒载量并减轻病毒诱导的肺病理改变。
要点
- 艾叶甲醇提取物体外具广谱抗IAV活性且细胞毒性低。
- AAE通过抑制PI3K-AKT通路激活发挥抗病毒与抗炎作用。
- H1N1小鼠模型中AAE提高生存率、降低肺病毒载量并减轻肺病理。
核心结论
- 艾叶甲醇提取物(AAE)在体外和体内均显示抗甲型流感病毒作用,机制与抑制宿主PI3K-AKT通路激活相关。
研究设计与样本
- 体外评估AAE抗IAV活性,采用代谢组学、转录组学和网络药理学多组学方法预测机制并经实验验证,并在致死性H1N1小鼠模型中评估疗效。
主要发现
- AAE exhibited potent broad-spectrum anti-influenza activity with low cytotoxicity.
- 多组学分析揭示AAE主要靶向宿主PI3K-AKT信号通路。
- 实验验证AAE通过抑制该通路激活诱导感染细胞凋亡并减弱过度宿主炎症反应。
- 体内研究显示AAE治疗显著提高生存率、降低肺病毒载量并减轻病毒诱导的肺病理改变。
临床怎么用
- 本研究为艾叶传统用于防治疫病提供科学依据,提示AAE可作为广谱抗流感候选药物进一步开发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Artemisia argyi (A. argyi) is a traditional medicinal herb widely used in East Asia for treating inflammation-related diseases. Its historical applications include fumigating to prevent pestilence and processing into moxa for moxibustion to enhance immunity, suggesting potential antiviral properties that align with its traditional use in "preventing plague". AIM OF THE STUDY: The increasing prevalence of drug-resistant Influenza A virus (IAV) strains and the limitations of existing antivirals necessitate the development of novel, broad-spectrum agents. This study aims to validate the traditional use of A. argyi by evaluating the anti-influenza efficacy of its methanol extract (AAE) and elucidating its underlying mechanism of action. MATERIALS AND METHODS: The antiviral activity of AAE against influenza A virus (IAV) was assessed in vitro. A multi-omics approach integrating metabolomics, transcriptomics, and network pharmacology was employed to predict the potential mechanisms, which were subsequently validated through experimental assays. Furthermore, the therapeutic efficacy of AAE was evaluated in a lethal H1N1 mouse model by monitoring survival rates, lung viral titer, and histopathological changes. RESULTS: AAE exhibited potent broad-spectrum anti-influenza activity with low cytotoxicity. Multi-omics analyses revealed that AAE primarily targets the host's PI3K-AKT signaling pathway. Experimental validation confirmed that AAE inhibits viral replication by suppressing the activation of this pathway, thereby inducing apoptosis in infected cells and attenuating excessive host inflammatory responses. Crucially, in vivo studies demonstrated that AAE treatment significantly enhanced survival rates, reduced lung viral loads, and alleviated virus-induced pulmonary pathology in mice. CONCLUSION: This study provides a scientific basis for the traditional use of Artemisia argyi against viral infections. Our findings demonstrate that AAE is a promising broad-spectrum anti-influenza agent with efficacy both in vitro and in vivo. Its mechanism acts through the PI3K-AKT pathway, highlighting the potential of ethnopharmacology-driven approaches for developing multi-targeted antiviral therapies.
引用
- Yang L, Li C, Li Y, et al. Methanol extract of Artemisia argyi against influenza a virus via inhibition of PI3K-AKT pathway activation. J Ethnopharmacol. 2025. PMID: 41317814. doi:10.1016/j.jep.2025.120973
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。